The Latest Cancer Drugs News
Browsing: Cancer Drug News
Drug designed to boost radiotherapy for hard to treat cancers taken safely by patients
A new drug designed to make radiotherapy more effective in treating cancer has been given…
Cancer drug trial studies urged to report harms transparently
Many reports of cancer drug trials use general or subjective terms to describe harms, finds…
New kind of compound shows early promise against prostate cancer
A new type of molecule blocks the action of genes that drive the growth of…
ESMO 2018: Zoledronic acid improves disease-free survival in premenopausal HR early breast cancer
Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase…
ESMO 2018: Erlotinib improves progression-free survival in early mutated non-small cell lung cancer
Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection of…
ESMO 2018: Olaparib maintenance extends PFS by estimated 3 years in advanced ovarian cancer
Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to…
ESMO 2018: Drugs for treating breast cancer in women are effective and well tolerated in men
There is growing evidence that drugs approved for the treatment of breast cancer in women…
ESMO 2018: Avelumab plus axitinib significantly improve PFS in untreated renal cell carcinoma
A combination of the immune checkpoint blocker, , plus the tyrosine kinase inhibitor (TKI), axitinib,…
Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with high-risk stage three melanoma
Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with…
Anti-psychotic drug could treat aggressive breast cancer
A commonly-used anti-psychotic drug could also be effective against triple negative breast cancer, the form…